The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis

Biomedicine and Pharmacotherapy

Volumn 63, Issue 5, 2009, Pages 362-365

  Actis, Giovanni C ^a   Fadda, Maurizio ^a   Pellicano, Rinaldo ^a   David, Ezio ^b   Rizzetto, Mario ^a   Sapino, Anna ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Azathioprine; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN;

ADULT; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; HUMAN; INFECTION; LEUKOPENIA; LIVER FUNCTION TEST; MALE; PANCREATITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT; TOXIC HEPATITIS; TREATMENT DURATION; ULCERATIVE COLITIS;

ADULT; AZATHIOPRINE; COLECTOMY; COLITIS, ULCERATIVE; COLONOSCOPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 68649113762     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.06.029     Document Type: Article

References (19)

1. Sands B.E. New therapies for the treatment of inflammatory bowel disease. Surg Clin North Am 86 (2006) 1045-1064
2. Tiede I., Fritz G., Strand S., Poppe D., Dvorsky R., Strand D., et al. CD-28 dependent Rac-1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 111 (2003) 1133-1145
3. Bean R.H.P. The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med J Aust 2 (1962) 592-593
4. Present D.H., Korelitz B.I., Wisch N., Glass J.L., Sachar D.B., and Pasternack B.S. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomised, double-blind study. N Engl J Med 302 (1980) 981-987
5. Leung Y., Panaccione R., Hemmelgarn B., and Jones J. Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis. Dig Dis Sci (2007 Oct 12) Epub ahead of print
6. Sands B.E. Immunosuppressive drugs in ulcerative colitis: twisting the facts to suit theories?. Gut 55 (2006) 437-441
7. Actis G.C., Bresso F., Astegiano M., Demarchi B., Sapone N., and Boscaglia C. Safety and efficacy of azathioprine in the maintenance of cyclosporin-induced remission of ulcerative colitis. Aliment Pharmacol Ther 15 (2001) 1307-1311
8. Actis G.C., Fadda M., David E., and Sapino A. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study. BMC Gastroenterol 7 (2007) 13
9. Ardizzone S., Maconi G., Russo A., Imbesi V., Colombo E., and Bianchi-Porro G. Randomized controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid-dependent ulcerative colitis. Gut 55 (2006) 47-53
10. Warman J.I., Korelitz B.I., Fleisher M.R., and Janardhanam R. Cumulative experience with short and long term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 37 (2003) 220-225
11. Glazier K.D., Palance A.L., Griffel L.H., and Das K.M. The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. J Clin Gastroenterol 39 (2005) 21-26
12. Nielsen O.H., Vainer B., and Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15 (2001) 1699-1708
13. Jewell D.P., Satsangi J., Lobo A., Probert C., Forbes A., Ghosh S., et al. Infliximab use in Crohn's disease: impact on health care resources in the UK. Eur J Gastroenterol Hepatol 17 (2005) 1047-1052
14. Gisbert J.P., Niño P., Cara C., and Rodrigo L. Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study on 394 patients. Aliment Pharmacol Ther (2008) doi:10.1111/j.1365-2036.2008.03732.x
15. Kornbluth A. Immunomodulators in ulcerative colitis. In: Bayless T., and Hanauer S.B. (Eds). Advanced therapy of inflammatory bowel disease (2001), BC Decker Inc, Hamilton-London 139
16. Matula S., Croog V., Itzkowitz S., Harpaz N., Bodian C., Hossain S., et al. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol 3 (2005) 1015-1021
17. Froslie K.F., Jahnsen J., Moum B.A., Vatn M.H., and IBSEN Group. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133 (2007) 412-422
18. Siegel C.A., and Sands B.E. Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther 22 (2005) 1-16
19. Fargher E.A., Tricker K., Newman W., Elliott R., Roberts S.A., Shaffer J.L., et al. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther 32 (2007) 187-195